116 related articles for article (PubMed ID: 38471603)
1. Optimizing long-term stability of siRNA using thermoassemble ionizable reverse pluronic-Bcl2 micelleplexes.
De A; Kang JH; Sauraj ; Lee OH; Ko YT
Int J Biol Macromol; 2024 Apr; 264(Pt 2):130783. PubMed ID: 38471603
[TBL] [Abstract][Full Text] [Related]
2. Cation-Free siRNA Micelles as Effective Drug Delivery Platform and Potent RNAi Nanomedicines for Glioblastoma Therapy.
Jiang T; Qiao Y; Ruan W; Zhang D; Yang Q; Wang G; Chen Q; Zhu F; Yin J; Zou Y; Qian R; Zheng M; Shi B
Adv Mater; 2021 Nov; 33(45):e2104779. PubMed ID: 34751990
[TBL] [Abstract][Full Text] [Related]
3. Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric mixed micelles for glioblastoma multiforme.
Saxena V; Hussain MD
Colloids Surf B Biointerfaces; 2013 Dec; 112():350-5. PubMed ID: 24012704
[TBL] [Abstract][Full Text] [Related]
4. Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment.
Zou Y; Sun X; Wang Y; Yan C; Liu Y; Li J; Zhang D; Zheng M; Chung RS; Shi B
Adv Mater; 2020 Jun; 32(24):e2000416. PubMed ID: 32374446
[TBL] [Abstract][Full Text] [Related]
5. A size-shrinkable matrix metallopeptidase-2-sensitive delivery nanosystem improves the penetration of human programmed death-ligand 1 siRNA into lung-tumor spheroids.
Wen J; Qiu N; Zhu Z; Bai P; Hu M; Qi W; Liu Y; Wei A; Chen L
Drug Deliv; 2021 Dec; 28(1):1055-1066. PubMed ID: 34078185
[TBL] [Abstract][Full Text] [Related]
6. Pluronic mixed micelles overcoming methotrexate multidrug resistance: in vitro and in vivo evaluation.
Chen Y; Sha X; Zhang W; Zhong W; Fan Z; Ren Q; Chen L; Fang X
Int J Nanomedicine; 2013; 8():1463-76. PubMed ID: 23620663
[TBL] [Abstract][Full Text] [Related]
7. Single pot organic solvent-free thermocycling technology for siRNA-ionizable LNPs: a proof-of-concept approach for alternative to microfluidics.
De A; Ko YT
Drug Deliv; 2022 Dec; 29(1):2644-2657. PubMed ID: 35949146
[TBL] [Abstract][Full Text] [Related]
8. Influence of nano-carrier architecture on in vitro siRNA delivery performance and in vivo biodistribution: polyplexes vs micelleplexes.
Gary DJ; Lee H; Sharma R; Lee JS; Kim Y; Cui ZY; Jia D; Bowman VD; Chipman PR; Wan L; Zou Y; Mao G; Park K; Herbert BS; Konieczny SF; Won YY
ACS Nano; 2011 May; 5(5):3493-505. PubMed ID: 21456626
[TBL] [Abstract][Full Text] [Related]
9. [Preparation, characterization of paclitaxel-loaded Pluronic P105 polymeric micelles and in vitro reversal of multidrug resistant tumor].
Wang YZ; Fang XL; Li YJ; Zhang ZW; Han LM; Sha XY
Yao Xue Xue Bao; 2008 Jun; 43(6):640-6. PubMed ID: 18822969
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of chemosensitizing siRNA and an anticancer agent via multiple monocomplexation-induced hydrophobic association.
Lee E; Oh C; Kim IS; Kwon IC; Kim S
J Control Release; 2015 Jul; 210():105-14. PubMed ID: 25979325
[TBL] [Abstract][Full Text] [Related]
11. Redox responsive Pluronic micelle mediated delivery of functional siRNA: a modular nano-assembly for targeted delivery.
Kadekar S; Nawale GN; Rangasami VK; Le Joncour V; Laakkonen P; Hilborn J; Varghese OP; Oommen OP
Biomater Sci; 2021 Jun; 9(11):3939-3944. PubMed ID: 34002185
[TBL] [Abstract][Full Text] [Related]
12. Pluronic F127-based micelles for tumor-targeted bufalin delivery.
Wang H; Williams GR; Wu J; Wu J; Niu S; Xie X; Li S; Zhu LM
Int J Pharm; 2019 Mar; 559():289-298. PubMed ID: 30707933
[TBL] [Abstract][Full Text] [Related]
13. Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.
Tong WY; Alnakhli M; Bhardwaj R; Apostolou S; Sinha S; Fraser C; Kuchel T; Kuss B; Voelcker NH
J Nanobiotechnology; 2018 Apr; 16(1):38. PubMed ID: 29653579
[TBL] [Abstract][Full Text] [Related]
14. c(RGDyK)-decorated Pluronic micelles for enhanced doxorubicin and paclitaxel delivery to brain glioma.
Huang Y; Liu W; Gao F; Fang X; Chen Y
Int J Nanomedicine; 2016; 11():1629-41. PubMed ID: 27143884
[TBL] [Abstract][Full Text] [Related]
15. Overcoming endosomal barrier by amphotericin B-loaded dual pH-responsive PDMA-b-PDPA micelleplexes for siRNA delivery.
Yu H; Zou Y; Wang Y; Huang X; Huang G; Sumer BD; Boothman DA; Gao J
ACS Nano; 2011 Nov; 5(11):9246-55. PubMed ID: 22011045
[TBL] [Abstract][Full Text] [Related]
16. Spray-dried powders enhance vaginal siRNA delivery by potentially modulating the mucus molecular sieve structure.
Wu N; Zhang X; Li F; Zhang T; Gan Y; Li J
Int J Nanomedicine; 2015; 10():5383-96. PubMed ID: 26347257
[TBL] [Abstract][Full Text] [Related]
17. Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment.
Peng Y; Huang J; Xiao H; Wu T; Shuai X
Int J Nanomedicine; 2018; 13():3467-3480. PubMed ID: 29942129
[TBL] [Abstract][Full Text] [Related]
18. pH-responsive DNA nanomicelles for chemo-gene synergetic therapy of anaplastic large cell lymphoma.
Li Y; Yue S; Cao J; Zhu C; Wang Y; Hai X; Song W; Bi S
Theranostics; 2020; 10(18):8250-8263. PubMed ID: 32724469
[TBL] [Abstract][Full Text] [Related]
19. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
Gu J; Al-Bayati K; Ho EA
Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer.
Xu C; Wang P; Zhang J; Tian H; Park K; Chen X
Small; 2015 Sep; 11(34):4321-33. PubMed ID: 26136261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
